iRhythm Holdings shares have fallen sharply this year, and that kind of reset naturally raises a question for investors about how the current price lines up with the company’s sales base. After a stretch of mixed headlines around product timelines and revenue trends, the key issue is how much of iRhythm’s commercial story is already reflected in a US$90.22 stock. The share price is down 48.5% year to date, which puts the focus on whether the current valuation still matches what iRhythm’s...
iRhythm Holdings (IRTC) stock wins a new Overweight and a $160 target from Piper Sandler, which argues that its YTD selloff is overdone. Read more here.
Detailed price information for Option Care Health Inc (OPCH-Q) from The Globe and Mail including charting and trades.
Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.
Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how patient monitoring stocks fared in Q2, starting with iRhythm (NASDAQ:IRTC).
Opportunities center on AI-enabled wearable ECG bands, remote monitoring, point-of-care diagnostics and home use, driven by telemedicine and preventive care, especially in emerging markets. Mobile ECG Devices Market Mobile ECG Devices Market Dublin, Sept. 02, 2026 (GLOBE NEWSWIRE) -- The "Mobile ECG Devices Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global mobile ECG devices market is experiencing strong growth as healthcare provi
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will...
iRhythm Holdings (IRTC) informed investors that Board member and Audit Committee chair Brian Yoor resigned for personal reasons on August 12, 2026. Existing director Karen McGinnis will step in to chair the Audit Committee. iRhythm Holdings’ share price has been volatile over 2026, with a 30 day share price return of 12.72% and a 7 day gain of 6.81%. However, the year to date share price return is down 29.75% and the 1 year total shareholder return is down 26.74%, even though the 5 year total...
This is the newest page. Registered accounts read further back.